Thyroid Stimulating Hormone (TSH)

A diagnostic blood test measuring pituitary TSH levels to evaluate thyroid gland function, screening for primary hypothyroidism, hyperthyroidism, and subclinical thyroid disorders.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

Specimen TypeVenous Blood (Serum)
PreparationFasting optional; early morning draw is preferred
Turnaround Time12–24 Hours
Clinical CategoryEndocrine Screen

Evidence Summary

Body SystemEndocrine
Typical PrevalenceStandard endocrine biomarker
Typical Age RangeAll age groups
Clinical Urgencyroutine
Primary Etiological Factors
  • Primary thyroid gland failure (elevated TSH)
  • Pituitary adenoma or central failure (suppressed/low TSH)
Recommended Screenings
Free T4Free T3Anti-TPO Autoantibodies
High-Yield Clinical Pearl

"TSH fluctuates diurnally, peaking overnight. A borderline elevation should always be confirmed with an early morning repeat specimen."

Visual Body System Card

Affected SystemEndocrine
Organs Involved
Pituitary GlandThyroid Gland
Hormones Involved
TSHTRHT4T3

TSH Laboratory Reference Ranges & Clinical Interpretation

SuppressedOptimal RangeSubclinical HypoOvert Hypo0.00.452.5 (Target)4.510.0mIU/LTSH Spectrum (mIU/L)

Note: Standard diagnostic range for adults is typically 0.45 - 4.5 mIU/L. Values outside these boundaries warrant Free T4 evaluation.

Laboratory Interpretation Workflow

Stage 1 of 5

1. Clinical Indication

Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.

Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.

Test Description & Overview

Thyroid Stimulating Hormone (TSH (Thyroid Stimulating Hormone, the master regulator of metabolic rate), thyrotropin) is a pituitary glycoprotein hormone that regulates thyroid hormone (T4/T3) synthesis and secretion. Serum TSH (Thyroid Stimulating Hormone, the master regulator of metabolic rate) is the primary diagnostic screen for thyroid axis function due to the inverse log-linear relationship between TSH (Thyroid Stimulating Hormone, the master regulator of metabolic rate) and serum free T4.

Standard Reference Range

Adult Non-Pregnant TSH: 0.45–4.50 mIU/L; First Trimester Pregnancy: 0.10–2.50 mIU/L; Free T4: 0.8–1.8 ng/dL; Free T3: 2.3–4.2 pg/mL.

Elevated (High) Values

  • Primary Hypothyroidism (TSH > 4.5 mIU/L with low Free T4)
  • Subclinical Hypothyroidism (TSH > 4.5 mIU/L with normal Free T4)
  • TSH-secreting pituitary adenoma or thyroid hormone resistance (rare causes of high TSH with high Free T4)

Decreased (Low) Values

  • Primary Hyperthyroidism / Thyrotoxicosis (TSH < 0.45 mIU/L with elevated Free T4/T3, e.g., Graves' disease, toxic nodular goiter)
  • Subclinical Hyperthyroidism (TSH < 0.10 mIU/L with normal Free T4/T3)
  • Central / Secondary Hypothyroidism (low or inappropriately normal TSH with low Free T4 due to pituitary failure)

Clinical Alignment & Significance

TSH is the initial screening biomarker. If TSH is abnormal, reflex Free T4 and thyroid autoantibodies (Anti-TPO, Anti-Thyroglobulin) delineate autoimmune etiology (Hashimoto's thyroiditis vs Graves' disease). Serum TSH fluctuations require morning repeat confirmation.

Clinician TSH Interpretation Flowchart

Diagnostic Action

Measure initial serum TSH level

Decision Point

Is TSH level elevated (> 4.5 mIU/L)?

YesEvaluate Free T4NoCheck for low TSH (< 0.4 mIU/L)
Diagnostic Action

Measure Free T4 level

Decision Point

Is Free T4 level decreased?

YesConfirm Primary HypothyroidismNoSubclinical Hypothyroidism
Clinical Consideration

Screen for Anti-TPO autoantibodies to evaluate for autoimmune etiology (Hashimoto's)

Clinical Consideration

Correlate with clinical findings (hypometabolic symptoms, bradycardia) to guide care

Diagnostic Guidance Notice

Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0012Jonklaas J., Bianco A. C., Bauer A. J., et al.. "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." Thyroid (2014).DOI PubMed
  • CIT-0013Garber J. R., Cobin R. H., Gharib H., et al.. "Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association." Endocrine Practice (2012).DOI PubMed
  • CIT-0014Demers L. M., Spencer C. A.. "Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease." National Academy of Clinical Biochemistry (NACB) (2002).
Clinical Reviews & Textbooks
  • CIT-0022Jethwani N.. "Internal Clinical Review Note: Standard Reference Values and Homeopathic Therapeutic Mappings for Lab Diagnostics." Homeo Healthcare Internal Review Series (2026).

AI & Generative Search Citation Block

Entity IDL0002
Entity Typelab-test
Content Versionv1.1.0
Last Reviewed DateJul 30, 2026
Evidence LevelLevel-A
Suggested Academic/LLM Citation format (AMA Style)

Dr. Narayan Jethwani. "Thyroid Stimulating Hormone (TSH)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-30T12:00:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/tsh

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.